Abstract:Occurrence and intensity of systemic invasive fungal infections have significantly risen in recent decades with large amount of mortality and morbidity rates at global level. Treatment therapy lies on the current antifungal interventions and are often limited due to the emergence of resistance to antifungal agents. Chemosensitization of fungal strains to the conventional antimycotic drugs are of growing concern. Current antifungal drugs often have been reported with poor activity and side effects to the host and have a few number of targets to manifest their efficacy on the pathogens. Indiscriminately, the aforementioned issues have been easily resolved by the development of new intervention strategies. One such approach is to employ combinational therapy that has exhibited a great level of inhibitions than that of a single compound. Chemosensitization of pathogenic mycoses to commercial antifungal drugs could be drastically enhanced by co-application of chemosensitizers along with the conventional drugs. Chemosensitizers could address the resistance mechanisms evolved in the pathogenic fungi and targeting the system to make the organism susceptible to commercially and clinically proven antifungal drugs. However, this strategy has not been overreached to the greater level, but it needs much attention to fight against not only with the pathogen but combat the resistance mechanisms of pathogens to drugs. Natural compounds including plant compounds and microbial proteins act as potential chemosensitizers to break the resistance in mycoses. Aspergillus giganteus , a filamentous fungus, is known to produce a cysteine rich extracellular protein called as antifungal protein (AFP). AFP has shown enhanced efficacy against several filamentous and non-filamentous fungal pathogens. On the basis of the reported studies on its targeted potential against pathogenic mycoses, AFP would be fabricated as a good chemosensitizer to augment the fungicidal efficacy of commercial antimycotic drugs. This paper reviews on breakthrough in the discovery of antifungal drugs along with the resistance patterns of mycoses to commercial drugs followed by the current intervention strategies applied to augment the fungicidal potential of drugs.

Update on antifungal drug resistance mechanisms of Aspergillus fumigatus

Antifungal resistance mechanisms of Aspergillus.

The progress in antifungal resistance of pathogenic Aspergillus spp.

Aspergillus fumigatus and aspergillosis: From basics to clinics

The molecular mechanism of azole resistance in Aspergillus fumigatus : from bedside to bench and back

Update on the Fungal Biofilm Drug Resistance and Its Alternative Treatment

Recent Advances and Future Perspectives in Mitigating Invasive Antifungal-Resistant Pathogen Aspergillus fumigatus in Africa

Antifungal drug resistance: an update

The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens

(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples

Aspergillus fumigatus escape mechanisms from its harsh survival environments

Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies

Antifungal Resistance in Pulmonary Aspergillosis

ANTIFUNGAL RESISTANCE: A GROWING CONCERN

Azole‐resistant Aspergillus fumigatus as an emerging worldwide pathogen

Fungal Infections as an Uprising Threat to Human Health: Chemosensitization of Fungal Pathogens With AFP From Aspergillus giganteus

Azole resistance in Aspergillus fumigatus: a growing public health concern

Antifungal drug resistance: do molecular methods provide a way forward?

An Insight into New Strategies to Combat Antifungal Drug Resistance

Diagnostics and susceptibility testing in Aspergillus

New antifungal drugs and new clinical trials: interpreting results may be difficult